Psoriasis and Risk of Incident Cancer: An Inception Cohort Study with a Nested Case– Control Analysis  Yolanda B. Brauchli, Susan S. Jick, Montserrat Miret, Christoph R. Meier  Journal of Investigative Dermatology  Volume 129, Issue 11, Pages 2604-2612 (November 2009) DOI: 10.1038/jid.2009.113 Copyright © 2009 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 1 Psoriasis duration and risk of cancer by specific cancer type. Ca/Co, number of cases and controls on which the results are based; CTCL, cutaneousT-cell lymphoma; MD, other myeloproliferative disorders. Odds ratios are adjusted for age, sex, and calendar time, by matching, and for smoking, body mass index, presence of benign cancer (all cancers), presence of gastro-oesophageal reflux disease (digestive organ cancers), use of proton-pump inhibitors (digestive organ cancers), presence of chronic obstructive pulmonary disease (lung cancer), and for the use of estrogens, progestagens, or oral contraceptives (breast cancer). Journal of Investigative Dermatology 2009 129, 2604-2612DOI: (10.1038/jid.2009.113) Copyright © 2009 The Society for Investigative Dermatology, Inc Terms and Conditions